Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

SELL
$0.64 - $6.49 $149 - $1,518
-234 Reduced 1.66%
13,853 $14,000
Q3 2023

Nov 06, 2023

BUY
$6.56 - $10.95 $242 - $405
37 Added 0.26%
14,087 $96,000
Q2 2023

Aug 01, 2023

BUY
$7.89 - $10.64 $4,142 - $5,586
525 Added 3.88%
14,050 $145,000
Q1 2023

Apr 27, 2023

BUY
$7.07 - $17.95 $2,516 - $6,390
356 Added 2.7%
13,525 $109,000
Q4 2022

Feb 07, 2023

BUY
$14.33 - $18.37 $7,222 - $9,258
504 Added 3.98%
13,169 $207,000
Q3 2022

Nov 07, 2022

BUY
$13.07 - $18.22 $13,723 - $19,131
1,050 Added 9.04%
12,665 $199,000
Q2 2022

Jul 28, 2022

SELL
$10.16 - $17.08 $8,107 - $13,629
-798 Reduced 6.43%
11,615 $162,000
Q1 2022

May 04, 2022

BUY
$9.74 - $17.92 $545 - $1,003
56 Added 0.45%
12,413 $214,000
Q4 2021

Feb 04, 2022

BUY
$12.27 - $18.49 $3,349 - $5,047
273 Added 2.26%
12,357 $180,000
Q3 2021

Nov 12, 2021

BUY
$13.38 - $18.8 $161,683 - $227,179
12,084 New
12,084 $218,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.